Role of Pentoxifylline and/or IgM-Enriched Intravenous Immunoglobulin in the Management of Neonatal Sepsis

American Journal of Perinatology

Volumn 31, Issue 10, 2014, Pages 905-912

  Akdag, Arzu ^a   Dilmen, Ugur ^a   Haque, Khalide ^b   Dilli, Dilek ^a   Erdeve, Omer ^a   Goekmen, Tuelin ^a  

^a Department of Gynecology and Obstetrics   (Turkey)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

IgM enriched intravenous immunoglobulin; newborn; pentoxifylline; sepsis

Indexed keywords

C REACTIVE PROTEIN; CD64 ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 6; PENTOXIFYLLINE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTOR; INTERLEUKIN 1;

ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDEMA; EVALUATION STUDY; FEMALE; FEVER; FLUSHING; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPOTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEWBORN; NEWBORN CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; NEWBORN VOMITING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TREATMENT DURATION; BLOOD; DRUG COMBINATION; METABOLISM; MICROBIOLOGY; SEPSIS; SURVIVAL RATE; TIME;

C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; INTERLEUKIN-1; MALE; PENTOXIFYLLINE; PROSPECTIVE STUDIES; RECEPTORS, IGG; SEPSIS; SURVIVAL RATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929941677     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1363771     Document Type: Article

References (41)

1. Stoll B. J., Hansen N. I., Bell E. F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics: 2010; 126 3 443 456
2. Lawn J. E., Wilczynska-Ketende K., Cousens S. N. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol: 2006; 35 3 706 718
3. Grether J. K., Nelson K. B. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA: 1997; 278 3 207 211
4. Stoll B. J., Hansen N. I., Adams-Chapman I., et al. National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA: 2004; 292 19 2357 2365
5. Tiskumara R., Fakharee S. H., Liu C. Q., et al. Neonatal infections in Asia. Arch Dis Child Fetal Neonatal Ed: 2009; 94 2 F144 F148
6. Talbert A. W., Mwaniki M., Mwarumba S., Newton C. R., Berkley J. A. Invasive bacterial infections in neonates and young infants born outside hospital admitted to a rural hospital in Kenya. Pediatr Infect Dis J: 2010; 29 10 945 949
7. Bader D., Kugelman A., Boyko V., et al. Risk factors and estimation tool for death among extremely premature infants: a national study. Pediatrics: 2010; 125 4 696 703
8. Haque K. N., Zaidi M. H., Bahakim H. IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child: 1988; 142 12 1293 1296
9. Cohen-Wolkowiez M., Benjamin D. K. Jr, Capparelli E. Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis. Curr Opin Pediatr: 2009; 21 2 177 181
10. Wynn J., Cornell T. T., Wong H. R., Shanley T. P., Wheeler D. S. The host response to sepsis and developmental impact. Pediatrics: 2010; 125 5 1031 1041
11. Tarnow-Mordi W., Isaacs D., Dutta S. Adjunctive immunologic interventions in neonatal sepsis. Clin Perinatol: 2010; 37 2 481 499
12. Ohlsson A., Lacy J. B. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev: 2010; 3 3 CD001239
13. Ohlsson A., Lacy J. B. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev: 2004; 1 1 CD000361
14. Ohlsson A., Lacy J. B. Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev: 2013; 7 CD001239
15. Haque K. N., Zaidi M. H., Haque S. K., Bahakim H., el-Hazmi M., el-Swailam M. Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants. Pediatr Infect Dis: 1986; 5 6 622 625
16. Brocklehurst P., Farrell B., King A., et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med: 2011; 365 13 1201 1211
17. Haque K. N., Remo C., Bahakim H. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clin Exp Immunol: 1995; 101 2 328 333
18. Kreymann K. G., de Heer G., Nierhaus A., Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med: 2007; 35 12 2677 2685
19. Harris E., Schulzke S. M., Patole S. K. Pentoxifylline in preterm neonates: a systematic review. Paediatr Drugs: 2010; 12 5 301 311
20. Lauterbach R., Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr: 1996; 155 5 404 409
21. Lauterbach R., Pawlik D., Kowalczyk D., Ksycínski W., Helwich E., Zembala M. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med: 1999; 27 4 807 814
22. Haque K. N. Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med: 2005; 6 (3, Suppl): S45 S49
23. Ng E., Shah V. Erythromycin for feeding intolerance in preterm infants. Cochrane Database Syst Rev: 2001; 2 CD001815
24. Rajesh V. T., Singhi S., Kataria S. Tachypnoea is a good predictor of hypoxia in acutely ill infants under 2 months. Arch Dis Child: 2000; 82 1 46 49
25. Marik P. E., Lipman J. The definition of septic shock: implications for treatment. Crit Care Resusc: 2007; 9 1 101 103
26. Hebson C. L., Chanani N. K., Rigby M. R., et al. Safe and effective use of a glycemic control protocol for neonates in a cardiac ICU. Pediatr Crit Care Med: 2013; 14 3 284 289
27. Pawlik M. T., Schreyer A. G., Ittner K. P., et al. Early treatment with pentoxifylline reduces lung injury induced by acid aspiration in rats. Chest: 2005; 127 2 613 621
28. Haque K. N., Remo C., Bahakim H. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clin Exp Immunol: 1995; 101 2 328 333
29. Mathur N. B., Agarwal H. S., Maria A. Acute renal failure in neonatal sepsis. Indian J Pediatr: 2006; 73 6 499 502
30. Ahmad I. Necrotizing enterocolitis and spontaneous intestinal perforation. In: Fred K. A., Lebowitz H., eds. Lange Neonatalogy: Management, Procedures, On-Call Problems, Diseases, and Drugs. 6th ed. New York McGraw-Hill Companies, Inc: 2009; 590 595
31. Woods W. G., Luban N. L., Hilgartner M. W., Miller D. R. Disseminated intravascular coagulation in the newborn. Am J Dis Child: 1979; 133 1 44 46
32. Tarcan A., Tiker F., Güvenir H., Gürakan B. Hepatic involvement in perinatal asphyxia. J Matern Fetal Neonatal Med: 2007; 20 5 407 410
33. Erdem G., Yurdakök M., Tekinalp G., Ersoy F. The use of IgM-enriched intravenous immunoglobulin for the treatment of neonatal sepsis in preterm infants. Turk J Pediatr: 1993; 35 4 277 281
34. Werdan K. Supplemental immune globulins in sepsis. Clin Chem Lab Med: 1999; 37 3 341 349
35. Haque K. N. Use of Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis: A Pragmatic Review and Analysis. J Med Sci: 2010; 3 3 160 167
36. Zeni F., Pain P., Vindimian M., et al. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med: 1996; 24 2 207 214
37. Steeb G. D., Wilson M. A., Garrison R. N. Pentoxifylline preserves small-intestine microvascular blood flow during bacteremia. Surgery: 1992; 112 4 756 763, discussion 763-764
38. Haque K., Mohan P. Pentoxifylline for neonatal sepsis. Cochrane Database Syst Rev: 2003; 4 CD004205
39. Schönharting M. M., Schade U. F. The effect of pentoxifylline in septic shock--new pharmacologic aspects of an established drug. J Med: 1989; 20 1 97 105
40. Lissner R., Struff W. G., Autenrieth I. B., Woodcock B. G., Karch H. Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg Suppl: 1999; 584 584 17 25
41. Norrby-Teglund A., Haque K. N., Hammarström L. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med: 2006; 260 6 509 516